Global Human Milk Oligosaccharides (HMO) Market Insights and Forecast to 2031

Report ID: 1152814 | Published Date: Jan 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Human Milk Oligosaccharides (HMO) Product Introduction
    1.2 Market by Type
        1.2.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 2'-FL & 3-FL
        1.2.3 Sialyllactose
        1.2.4 LNT & LNnT
    1.3 Market by Application
        1.3.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Infant Formula
        1.3.3 Functional Food & Beverages
        1.3.4 Food/Medical Supplements
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Human Milk Oligosaccharides (HMO) Sales Estimates and Forecasts 2017-2028
    2.2 Global Human Milk Oligosaccharides (HMO) Revenue Estimates and Forecasts 2017-2028
    2.3 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Human Milk Oligosaccharides (HMO) Sales by Region
        2.4.1 Global Human Milk Oligosaccharides (HMO) Sales by Region (2017-2022)
        2.4.2 Global Sales Human Milk Oligosaccharides (HMO) by Region (2023-2028)
    2.5 Global Human Milk Oligosaccharides (HMO) Revenue by Region
        2.5.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2017-2022)
        2.5.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers
        3.1.1 Global Top Human Milk Oligosaccharides (HMO) Manufacturers by Sales (2017-2022)
        3.1.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Milk Oligosaccharides (HMO) in 2021
    3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers
        3.2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2017-2022)
        3.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Human Milk Oligosaccharides (HMO) Revenue in 2021
    3.3 Global Human Milk Oligosaccharides (HMO) Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Human Milk Oligosaccharides (HMO) Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Human Milk Oligosaccharides (HMO) Sales by Type
        4.1.1 Global Human Milk Oligosaccharides (HMO) Historical Sales by Type (2017-2022)
        4.1.2 Global Human Milk Oligosaccharides (HMO) Forecasted Sales by Type (2023-2028)
        4.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2017-2028)
    4.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type
        4.2.1 Global Human Milk Oligosaccharides (HMO) Historical Revenue by Type (2017-2022)
        4.2.2 Global Human Milk Oligosaccharides (HMO) Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2017-2028)
    4.3 Global Human Milk Oligosaccharides (HMO) Price by Type
        4.3.1 Global Human Milk Oligosaccharides (HMO) Price by Type (2017-2022)
        4.3.2 Global Human Milk Oligosaccharides (HMO) Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Human Milk Oligosaccharides (HMO) Sales by Application
        5.1.1 Global Human Milk Oligosaccharides (HMO) Historical Sales by Application (2017-2022)
        5.1.2 Global Human Milk Oligosaccharides (HMO) Forecasted Sales by Application (2023-2028)
        5.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2017-2028)
    5.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application
        5.2.1 Global Human Milk Oligosaccharides (HMO) Historical Revenue by Application (2017-2022)
        5.2.2 Global Human Milk Oligosaccharides (HMO) Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2017-2028)
    5.3 Global Human Milk Oligosaccharides (HMO) Price by Application
        5.3.1 Global Human Milk Oligosaccharides (HMO) Price by Application (2017-2022)
        5.3.2 Global Human Milk Oligosaccharides (HMO) Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Human Milk Oligosaccharides (HMO) Market Size by Type
        6.1.1 North America Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028)
        6.1.2 North America Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028)
    6.2 North America Human Milk Oligosaccharides (HMO) Market Size by Application
        6.2.1 North America Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028)
        6.2.2 North America Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028)
    6.3 North America Human Milk Oligosaccharides (HMO) Market Size by Country
        6.3.1 North America Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028)
        6.3.2 North America Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Human Milk Oligosaccharides (HMO) Market Size by Type
        7.1.1 Europe Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028)
        7.1.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028)
    7.2 Europe Human Milk Oligosaccharides (HMO) Market Size by Application
        7.2.1 Europe Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028)
        7.2.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028)
    7.3 Europe Human Milk Oligosaccharides (HMO) Market Size by Country
        7.3.1 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028)
        7.3.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Type
        8.1.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028)
        8.1.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028)
    8.2 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Application
        8.2.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028)
        8.2.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028)
    8.3 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Region
        8.3.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2017-2028)
        8.3.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Human Milk Oligosaccharides (HMO) Market Size by Type
        9.1.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028)
        9.1.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028)
    9.2 Latin America Human Milk Oligosaccharides (HMO) Market Size by Application
        9.2.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028)
        9.2.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028)
    9.3 Latin America Human Milk Oligosaccharides (HMO) Market Size by Country
        9.3.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028)
        9.3.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Type
        10.1.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028)
    10.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Application
        10.2.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028)
    10.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country
        10.3.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Abbott
        11.1.1 Abbott Corporation Information
        11.1.2 Abbott Overview
        11.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Abbott Recent Developments
    11.2 Inbiose
        11.2.1 Inbiose Corporation Information
        11.2.2 Inbiose Overview
        11.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Inbiose Recent Developments
    11.3 Glycom
        11.3.1 Glycom Corporation Information
        11.3.2 Glycom Overview
        11.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Glycom Recent Developments
    11.4 Chr. Hansen (Jennewein)
        11.4.1 Chr. Hansen (Jennewein) Corporation Information
        11.4.2 Chr. Hansen (Jennewein) Overview
        11.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Chr. Hansen (Jennewein) Recent Developments
    11.5 Elicityl SA
        11.5.1 Elicityl SA Corporation Information
        11.5.2 Elicityl SA Overview
        11.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Elicityl SA Recent Developments
    11.6 ZuChem
        11.6.1 ZuChem Corporation Information
        11.6.2 ZuChem Overview
        11.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 ZuChem Recent Developments
    11.7 Dextra Laboratories
        11.7.1 Dextra Laboratories Corporation Information
        11.7.2 Dextra Laboratories Overview
        11.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Dextra Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Human Milk Oligosaccharides (HMO) Industry Chain Analysis
    12.2 Human Milk Oligosaccharides (HMO) Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Human Milk Oligosaccharides (HMO) Production Mode & Process
    12.4 Human Milk Oligosaccharides (HMO) Sales and Marketing
        12.4.1 Human Milk Oligosaccharides (HMO) Sales Channels
        12.4.2 Human Milk Oligosaccharides (HMO) Distributors
    12.5 Human Milk Oligosaccharides (HMO) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Human Milk Oligosaccharides (HMO) Industry Trends
    13.2 Human Milk Oligosaccharides (HMO) Market Drivers
    13.3 Human Milk Oligosaccharides (HMO) Market Challenges
    13.4 Human Milk Oligosaccharides (HMO) Market Restraints
14 Key Findings in The Global Human Milk Oligosaccharides (HMO) Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 2'-FL & 3-FL
    Table 3. Major Manufacturers of Sialyllactose
    Table 4. Major Manufacturers of LNT & LNnT
    Table 5. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Human Milk Oligosaccharides (HMO) Sales by Region (2017-2022) & (Tons)
    Table 8. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2017-2022)
    Table 9. Global Human Milk Oligosaccharides (HMO) Sales by Region (2023-2028) & (Tons)
    Table 10. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2023-2028)
    Table 11. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2017-2022)
    Table 13. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2023-2028)
    Table 15. Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers (2017-2022) & (Tons)
    Table 16. Global Human Milk Oligosaccharides (HMO) Sales Share by Manufacturers (2017-2022)
    Table 17. Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers (2017-2022)
    Table 19. Human Milk Oligosaccharides (HMO) Price by Manufacturers (2017-2022) &(USD/Ton)
    Table 20. Global Human Milk Oligosaccharides (HMO) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Human Milk Oligosaccharides (HMO) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Milk Oligosaccharides (HMO) as of 2021)
    Table 22. Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Human Milk Oligosaccharides (HMO) Product Offered
    Table 24. Date of Manufacturers Enter into Human Milk Oligosaccharides (HMO) Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Human Milk Oligosaccharides (HMO) Sales by Type (2017-2022) & (Tons)
    Table 27. Global Human Milk Oligosaccharides (HMO) Sales by Type (2023-2028) & (Tons)
    Table 28. Global Human Milk Oligosaccharides (HMO) Sales Share by Type (2017-2022)
    Table 29. Global Human Milk Oligosaccharides (HMO) Sales Share by Type (2023-2028)
    Table 30. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Human Milk Oligosaccharides (HMO) Revenue Share by Type (2017-2022)
    Table 33. Global Human Milk Oligosaccharides (HMO) Revenue Share by Type (2023-2028)
    Table 34. Human Milk Oligosaccharides (HMO) Price by Type (2017-2022) & (USD/Ton)
    Table 35. Global Human Milk Oligosaccharides (HMO) Price Forecast by Type (2023-2028) & (USD/Ton)
    Table 36. Global Human Milk Oligosaccharides (HMO) Sales by Application (2017-2022) & (Tons)
    Table 37. Global Human Milk Oligosaccharides (HMO) Sales by Application (2023-2028) & (Tons)
    Table 38. Global Human Milk Oligosaccharides (HMO) Sales Share by Application (2017-2022)
    Table 39. Global Human Milk Oligosaccharides (HMO) Sales Share by Application (2023-2028)
    Table 40. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Human Milk Oligosaccharides (HMO) Revenue Share by Application (2017-2022)
    Table 43. Global Human Milk Oligosaccharides (HMO) Revenue Share by Application (2023-2028)
    Table 44. Human Milk Oligosaccharides (HMO) Price by Application (2017-2022) & (USD/Ton)
    Table 45. Global Human Milk Oligosaccharides (HMO) Price Forecast by Application (2023-2028) & (USD/Ton)
    Table 46. North America Human Milk Oligosaccharides (HMO) Sales by Type (2017-2022) & (Tons)
    Table 47. North America Human Milk Oligosaccharides (HMO) Sales by Type (2023-2028) & (Tons)
    Table 48. North America Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Human Milk Oligosaccharides (HMO) Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Human Milk Oligosaccharides (HMO) Sales by Application (2017-2022) & (Tons)
    Table 51. North America Human Milk Oligosaccharides (HMO) Sales by Application (2023-2028) & (Tons)
    Table 52. North America Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Human Milk Oligosaccharides (HMO) Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Human Milk Oligosaccharides (HMO) Sales by Country (2017-2022) & (Tons)
    Table 55. North America Human Milk Oligosaccharides (HMO) Sales by Country (2023-2028) & (Tons)
    Table 56. North America Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Human Milk Oligosaccharides (HMO) Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Human Milk Oligosaccharides (HMO) Sales by Type (2017-2022) & (Tons)
    Table 59. Europe Human Milk Oligosaccharides (HMO) Sales by Type (2023-2028) & (Tons)
    Table 60. Europe Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Human Milk Oligosaccharides (HMO) Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Human Milk Oligosaccharides (HMO) Sales by Application (2017-2022) & (Tons)
    Table 63. Europe Human Milk Oligosaccharides (HMO) Sales by Application (2023-2028) & (Tons)
    Table 64. Europe Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Human Milk Oligosaccharides (HMO) Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2017-2022) & (Tons)
    Table 67. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2023-2028) & (Tons)
    Table 68. Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Type (2017-2022) & (Tons)
    Table 71. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Type (2023-2028) & (Tons)
    Table 72. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Application (2017-2022) & (Tons)
    Table 75. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Application (2023-2028) & (Tons)
    Table 76. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2017-2022) & (Tons)
    Table 79. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2023-2028) & (Tons)
    Table 80. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Human Milk Oligosaccharides (HMO) Sales by Type (2017-2022) & (Tons)
    Table 83. Latin America Human Milk Oligosaccharides (HMO) Sales by Type (2023-2028) & (Tons)
    Table 84. Latin America Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Human Milk Oligosaccharides (HMO) Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Human Milk Oligosaccharides (HMO) Sales by Application (2017-2022) & (Tons)
    Table 87. Latin America Human Milk Oligosaccharides (HMO) Sales by Application (2023-2028) & (Tons)
    Table 88. Latin America Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Human Milk Oligosaccharides (HMO) Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2017-2022) & (Tons)
    Table 91. Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2023-2028) & (Tons)
    Table 92. Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Type (2017-2022) & (Tons)
    Table 95. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Type (2023-2028) & (Tons)
    Table 96. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Application (2017-2022) & (Tons)
    Table 99. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Application (2023-2028) & (Tons)
    Table 100. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2017-2022) & (Tons)
    Table 103. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2023-2028) & (Tons)
    Table 104. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Abbott Corporation Information
    Table 107. Abbott Description and Major Businesses
    Table 108. Abbott Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 109. Abbott Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Abbott Recent Developments
    Table 111. Inbiose Corporation Information
    Table 112. Inbiose Description and Major Businesses
    Table 113. Inbiose Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 114. Inbiose Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Inbiose Recent Developments
    Table 116. Glycom Corporation Information
    Table 117. Glycom Description and Major Businesses
    Table 118. Glycom Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 119. Glycom Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Glycom Recent Developments
    Table 121. Chr. Hansen (Jennewein) Corporation Information
    Table 122. Chr. Hansen (Jennewein) Description and Major Businesses
    Table 123. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 124. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Chr. Hansen (Jennewein) Recent Developments
    Table 126. Elicityl SA Corporation Information
    Table 127. Elicityl SA Description and Major Businesses
    Table 128. Elicityl SA Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 129. Elicityl SA Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Elicityl SA Recent Developments
    Table 131. ZuChem Corporation Information
    Table 132. ZuChem Description and Major Businesses
    Table 133. ZuChem Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 134. ZuChem Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. ZuChem Recent Developments
    Table 136. Dextra Laboratories Corporation Information
    Table 137. Dextra Laboratories Description and Major Businesses
    Table 138. Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2017-2022)
    Table 139. Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Dextra Laboratories Recent Developments
    Table 141. Key Raw Materials Lists
    Table 142. Raw Materials Key Suppliers Lists
    Table 143. Human Milk Oligosaccharides (HMO) Distributors List
    Table 144. Human Milk Oligosaccharides (HMO) Customers List
    Table 145. Human Milk Oligosaccharides (HMO) Market Trends
    Table 146. Human Milk Oligosaccharides (HMO) Market Drivers
    Table 147. Human Milk Oligosaccharides (HMO) Market Challenges
    Table 148. Human Milk Oligosaccharides (HMO) Market Restraints
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Milk Oligosaccharides (HMO) Product Picture
    Figure 3. Global Human Milk Oligosaccharides (HMO) Market Share by Type in 2021 & 2028
    Figure 3. 2'-FL & 3-FL Product Picture
    Figure 4. Sialyllactose Product Picture
    Figure 5. LNT & LNnT Product Picture
    Figure 6. Global Human Milk Oligosaccharides (HMO) Market Share by Application in 2021 & 2028
    Figure 7. Infant Formula
    Figure 8. Functional Food & Beverages
    Figure 9. Food/Medical Supplements
    Figure 10. Others
    Figure 11. Human Milk Oligosaccharides (HMO) Report Years Considered
    Figure 12. Global Human Milk Oligosaccharides (HMO) Sales 2017-2028 (Tons)
    Figure 13. Global Human Milk Oligosaccharides (HMO) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Human Milk Oligosaccharides (HMO) Revenue 2017-2028 (US$ Million)
    Figure 15. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2017-2022)
    Figure 17. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2023-2028)
    Figure 18. North America Human Milk Oligosaccharides (HMO) Sales YoY (2017-2028) & (Tons)
    Figure 19. North America Human Milk Oligosaccharides (HMO) Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Human Milk Oligosaccharides (HMO) Sales YoY (2017-2028) & (Tons)
    Figure 21. Europe Human Milk Oligosaccharides (HMO) Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales YoY (2017-2028) & (Tons)
    Figure 23. Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Human Milk Oligosaccharides (HMO) Sales YoY (2017-2028) & (Tons)
    Figure 25. Latin America Human Milk Oligosaccharides (HMO) Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales YoY (2017-2028) & (Tons)
    Figure 27. Middle East & Africa Human Milk Oligosaccharides (HMO) Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Human Milk Oligosaccharides (HMO) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Human Milk Oligosaccharides (HMO) in the World: Market Share by Human Milk Oligosaccharides (HMO) Revenue in 2021
    Figure 30. Global Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2017-2028)
    Figure 32. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2017-2028)
    Figure 33. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2017-2028)
    Figure 34. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2017-2028)
    Figure 35. North America Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2017-2028)
    Figure 36. North America Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2017-2028)
    Figure 37. North America Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2017-2028)
    Figure 38. North America Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2017-2028)
    Figure 39. North America Human Milk Oligosaccharides (HMO) Sales Share by Country (2017-2028)
    Figure 40. North America Human Milk Oligosaccharides (HMO) Revenue Share by Country (2017-2028)
    Figure 41. U.S. Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2017-2028)
    Figure 44. Europe Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2017-2028)
    Figure 46. Europe Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Human Milk Oligosaccharides (HMO) Sales Share by Country (2017-2028)
    Figure 48. Europe Human Milk Oligosaccharides (HMO) Revenue Share by Country (2017-2028)
    Figure 49. Germany Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 50. France Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Human Milk Oligosaccharides (HMO) Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue Share by Region (2017-2028)
    Figure 60. China Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 63. India Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Human Milk Oligosaccharides (HMO) Sales Share by Country (2017-2028)
    Figure 75. Latin America Human Milk Oligosaccharides (HMO) Revenue Share by Country (2017-2028)
    Figure 76. Mexico Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue Share by Country (2017-2028)
    Figure 85. Turkey Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Human Milk Oligosaccharides (HMO) Revenue (2017-2028) & (US$ Million)
    Figure 88. Human Milk Oligosaccharides (HMO) Value Chain
    Figure 89. Human Milk Oligosaccharides (HMO) Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem
Dextra Laboratories
Frequently Asked Questions
Human Milk Oligosaccharides (HMO) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Milk Oligosaccharides (HMO) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Milk Oligosaccharides (HMO) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Insulin Pen Needles

Insulin Pen Needles market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More